Advancing Genomic Research
- Furthering investigation that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer
- Leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools
Serving as a Nexus for Collaboration
- Harnessing the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners
- For the New York scientific community and beyond
Leading Collaborative Research in Neurodegenerative Disease
Building on the success of NYGC’s global consortium for ALS research to drive discovery for conditions with common disease pathways, including Alzheimer’s, Parkinson’s, and Huntington’s
Expanding Understanding of Neuropsychiatric Disease
Leveraging our large-scale whole genome research of autism patients to related disorders that have commonly implicated genes, such as schizophrenia and bipolar disorder
Focusing on whole genome sequencing of individuals with cancer and their tumors, novel population-level cancer analytics, and the application of both single cell sequencing and spatial transcriptomics
The New York Genome Center (NYGC) is an independent, nonprofit academic research institution focused on furthering genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer, leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools.
We serve as a nexus for collaboration in genomic research for the New York community and beyond, building on the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners.
Central to this commitment is an outstanding faculty who are leading independent research labs based at the NYGC and one of our member institutions. They also support the NYGC scientific mission and engage in research programs that support the NYGC and the wider scientific community.
IN THE NEWS
The ALS Association and
The Tow Foundation Commit
Additional $6 Million
to New York Genome Center
New Funding to Support Center for Genomics of Neurodegenerative Disease
New York Cancer Genomics Research Network Meetings
These monthly meetings, moderated by Harold Varmus, MD, Senior Associate Core Member, NYGC, and Lewis Thomas University Professor of Medicine, Weill Cornell Medicine, bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions.
Developing New Genomic Tools & Technologies
Our scientists are focused on collaborative initiatives in single cell and spatial transcriptomics and the computational methods necessary to understand the underlying biology and disease mechanisms.
Our Technology Innovation Lab is a leader in developing new technologies for enhanced single-cell analysis, including CITE-seq and Cell Hashing, and making them widely accessible to the scientific community.
Furthering Scientific Inquiry
Our outstanding faculty and staff scientists are recognized as innovators in the field, and in the last five years have published over 200 papers in leading scientific journals helping to advance genomic science. They have received many awards and honors, including three prestigious NIH New Innovator Awards. Their important research has provided new insights, including the discovery of dozens of new genes that create cancer resistance and hundreds of genes that impact the human immune system. NYGC researchers have also contributed to the identification of a novel gene associated with ALS, and uncovered new genetic signatures for autism.